Does ROSIGLITAZONE Cause Left ventricular hypertrophy? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Left ventricular hypertrophy have been filed in association with ROSIGLITAZONE. This represents 0.1% of all adverse event reports for ROSIGLITAZONE.
31
Reports of Left ventricular hypertrophy with ROSIGLITAZONE
0.1%
of all ROSIGLITAZONE reports
8
Deaths
23
Hospitalizations
How Dangerous Is Left ventricular hypertrophy From ROSIGLITAZONE?
Of the 31 reports, 8 (25.8%) resulted in death, 23 (74.2%) required hospitalization.
Is Left ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does ROSIGLITAZONE Cause?
Myocardial infarction (17,018)
Cardiac failure congestive (15,085)
Cerebrovascular accident (7,899)
Coronary artery disease (4,982)
Acute myocardial infarction (2,437)
Cardiac disorder (1,732)
Coronary arterial stent insertion (1,698)
Coronary artery bypass (1,181)
Chest pain (990)
Myocardial ischaemia (970)
What Other Drugs Cause Left ventricular hypertrophy?
AMLODIPINE (158)
CLOZAPINE (149)
TACROLIMUS (135)
FUROSEMIDE (128)
PANTOPRAZOLE (117)
BISOPROLOL (114)
SACUBITRIL\VALSARTAN (105)
ASPIRIN (104)
ROSUVASTATIN (94)
CARVEDILOL (87)
Which ROSIGLITAZONE Alternatives Have Lower Left ventricular hypertrophy Risk?
ROSIGLITAZONE vs ROSUVASTATIN
ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN
ROSIGLITAZONE vs ROTIGOTINE
ROSIGLITAZONE vs ROXADUSTAT
ROSIGLITAZONE vs ROXICODONE